|
Internet Drug News.com |
||
6/14 Compromise Ruling on Gene Patents
U.S. top court bars patents on human genes unless synthetic .... The biotech industry saw some good in the ruling, noting that the justices left intact patent protections on forms of DNA produced by scientists in laboratories and the processes used to carry out tests such as cancer screenings .... [Reuters]
6/14 Eliquis and Xeljanz Hobble Off the Blocks
Pfizer's Two New Top Pills Selling Slower Than Expected .... While Eliquis is considered to have superior clinical data, its rivals were approved earlier and have had time to establish themselves with doctors and patients.... Some health insurers and drug benefit managers were limiting access to Xeljanz and forcing patients to try multiple other therapies before getting access to the new drug .... [Bloomberg]
6/14 New Oral for RA Progresses
Lilly says arthritis pill effective in mid-stage study .... Of the 196 patients in the study, 71 percent showed a 20 percent improvement in rheumatoid arthritis symptoms. .... [Reuters]
6/14 Grow Back Your Hair and Get Off the Sauce
Baldness Drug Curbs Men's Interest in Alcohol, Study Suggests .... Almost two-thirds of the men in the study noticed they were drinking less alcohol than before taking Propecia .... [Yahoo]
6/14 Oral Hepatitis C Cocktails to Double Number of Patients in Treatment
AbbVie Says It Can Be First With New Hepatitis C Drugs .... Multidrug regimens by AbbVie, Gilead and Bristol-Myers Squibb will offer hepatitis C patients more tolerable options that do away with weekly shots of interferon.... Gilead has estimated that 150,000 patients may seek treatment in the U.S. once the new class of all-oral drugs is on the market .... [Bloomberg]
6/14 Sneeze on Your Twitter This Fall, and Everyday Health Will Say 'Gesundheit'
Twitter-Everyday Health deal means targeted Tweets .... Twitter is partnering with the health media firm on HealthBeat, through which sponsored posts (promoted Tweets, in Twitter argot) touting contextually relevant content will be routed to Twitter users, triggered by keyword, location or other algorithmic tripwires .... [MM&M]
6/14 Xgeva Approved for Rare Cancer
FDA expands approval for Amgen's Xgeva for GCTB .... The FDA has broadened approval for Amgen's Xgeva (denosumab) to include the treatment of adults and some adolescents with giant cell tumour of the bone (GCTB), making it the first treatment cleared in the US for the rare disease .... [First Word Pharma]
6/14 Ustekinumab Helpful to Those Who Failed on Anti-TNF
Stelara Succeeds in Psoriatic Arthritis .... By 1 year, among patients receiving the 45 mg dose, 47% had ACR20 responses, while 28% and 13% had ACR50 and ACR70 responses .... [MedPage Today]
6/14 Vertex Bets the Third Drug's the Charm Against CF
These Mutated Cystic Fibrosis Cells Are Worth Billions to Vertex Pharma .... Vertex is demonstrating that triple-drug combinations can significantly improve the activity of cells with the hardest-to-treat cystic fibrosis mutations .... [The Street]
6/14 Part D Plans Could Save a Lot of Money with Generics
Brand-name drugs pushing up US Medicare costs .... Spending on Medicare's prescription drug benefit, known as Part D, would have been an estimated $1.4 billion less in 2008 if its brand-name and generic drug use had matched that of the VA for the medications studied .... [Pharma Times]
6/14 Internet Drug News Fast Takes:
Scant data on seizure drugs for women's genital pain
Reuters
Number of retail clinics to double by 2015
Advisory Board
Doctor Pay Rises To $221K For Primary Care, $396K For Specialists
Forbes
NICE knocks back Lilly's Alimta in new setting
PMLiVe
Fish on Prozac show the ill effects of waterways tainted with drug residue
Minn Post
6/13 Pre-Exposure Treatment Slows HIV Spread
Gilead's Viread Reduces HIV Risk for Drug Users in Study .... In a trial involving 2,413 HIV-negative drug users in Bangkok over five years, those who received Viread daily were 49 percent less likely to get infected with HIV than those who got a placebo .... [Bloomberg]
6/13 Teva and Sun Pay the Pfizer for Protonix
Aggressive Tactics Proved Too Risky For These Generic Drugmakers .... The $2.15 billion settlement is one of the highest tabs for damages from a so-called 'at-risk" launch of a generic drug .... [Wall Street Cheat Sheet]
6/13 New Drugs on the Way for Cardiovascular
PhRMA: 215 drugs under development for cardiovascular disease .... The drugs include 30 for heart failure, 29 for lipid disorders, 19 for stroke and 17 for high blood pressure .... [Drug Store News]
6/13 Out-of-Pocket Cap May Slide to 2015 for Some
A Delay In Relief From Copays For Costly Drugs .... The Affordable Care Act sets annual limits on the amount that people will owe out of pocket for prescription drugs starting in 2014. But sick people in some plans won't get relief until the following year because the federal government is giving some health plans extra time to comply .... [NPR]
6/13 NEJM Study Finds Biologic No Better Than Generic Combination
Study shows old-school meds as effective as Enbrel .... Researchers found they could match Enbrel's effectiveness by combining sulfasalazine and hydroxychloroquine with methotrexate, which is a common RA therapy .... [MM&M]
6/13 Trebananib Extends PFS 1.8 Months in Ovarian Ca
Amgen says drug slowed ovarian cancer in trial .... Amgen said median progression free survival (PFS) in the trial was 7.2 months for patients given trebananib and chemotherapy, compared with 5.4 months for patients treated with a placebo drug and chemotherapy .... [Reuters]
6/13 Insert Printers Fight for Their Lives
Who's fighting digital healthcare? The little guys who print paper drug inserts .... Robert Brooks, executive director of the Pharmaceutical Printed Literature Association, has toured Pharmaceutic Litho's Simi Valley facility and estimates 50 to 80 such printing businesses in the country would be wiped out if the bill were enacted .... [MedCity News]
6/13 New PBM for Cigna
Catamaran Gains Cigna's Prescription Drug Business .... Cigna will handle formulary management and customer service itself, and the pharmacy benefits will carry Cigna's brand name. Catamaran will perform the "behind the scenes, back office" work .... [Bloomberg]
6/13 Orencia Wants a Piece of the Action
BMS' Orencia matches Humira in arthritis study .... Both drugs achieved an ACR20 (American College of Rheumatology 20 per cent improvement) in around 60 per cent of patients after two year's therapy, with the onset of response also similar between the groups .... [PMLiVE]
6/13 ADA Does About-Face; Supports New Look at GLP-1 Drugs
Diabetes Drugs Under Scrutiny As FDA Considers Another Study .... The FDA is considering whether to run a study to determine whether a definitive link from GLP-1 drugs can be established to acute pancreatitis and pancreatic cancer .... [Pharmalot]
6/13 Internet Drug News Fast Takes:
Dying Girl Who Sparked Transplant Policy Change Gets Lung
Bloomberg
Music device doesn't drop diabetics' blood pressure
Reuters Health
Lab chief: Hundreds of doctors took bribes in Medicare fraud scheme
Advisory Board
Commonly-Prescribed Drugs May Influence the Onset and Progression of Alzheimer's Disease
Mount Sinai Medical Center
GSK offers discount to win UK green light for platelet drug
Reuters
|
6/12 Fast Takes |
||